Detalhe da pesquisa
1.
Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1603-1610, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002993
2.
Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy.
Hematol Oncol
; 35(4): 679-684, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27982454
3.
Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials.
Clin Pharmacokinet
; 60(4): 527-540, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33135125
4.
Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure-Response Analyses Underutilized?
CPT Pharmacometrics Syst Pharmacol
; 8(3): 138-145, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659774
5.
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia.
Clin Pharmacokinet
; 56(5): 515-523, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27638334
6.
Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis.
AAPS J
; 18(5): 1192-1202, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27233802
7.
Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.
Cancer Chemother Pharmacol
; 78(4): 847-53, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27586967